Nachrichten zur Johnson & Johnson Aktie

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

BEERSE, BELGIUM , June 03, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced nipocalimab met the…

Johnson & Johnson Hopes to Dethrone AbbVies Biggest Growth Driver. Heres Why Investors Shouldnt Panic

AbbVies shareholders can sleep easy.…

XOMA (XOMA) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEWednesday, March 18, 2026 at 8:00 a.m. ETCALL PARTICIPANTSChief Executive Officer — Owen HughesChief Investment Officer…

Johnson & Johnson: Diese zwei Entwicklungen könnten die Aktie antreiben

Johnson & Johnson ist einer der größten Gesundheitskonzerne der Welt und in den Bereichen Pharma, Medizintechnik sowie Gesundheitslösungen tätig. Das Unternehmen entwickelt…

TopBuild (BLD) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DateFeb. 26, 2026, 9:00 a.m. ETCall participantsChairman, President, and CEO — Robert BuckChief Operating Officer —…

Magic Johnson Says Victor Wembanyama’s Defensive Tactics ‘Won’t Work’ Against The Knicks

Magic Johnson Says Victor Wembanyama’s Defensive Tactics ‘Won’t Work’ Against The Knicks…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., May 29, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $225.33 at the closing of the latest trading day, reflecting a -2.37% change compared to…

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer

Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer are benefiting from innovation, pipeline growth and strong demand in key…

HURA: Refining TBS-2025 Development Plan

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn May 15th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Frontier IP portfolio company Dekiln to explore partnership with Johnson Tiles

Frontier IP has announced that portfolio company Dekiln has signed a Memorandum of Understanding with Johnson Tiles, one of the…

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Todays Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.…

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $231.73, marking a +1.05% move from the previous day.…

Gunnison Copper reports Q1 profit as Johnson Camp ramp-up continues

Gunnison Copper Corp (TSX:GCU, OTCQB:GCUMF, FRA:3XS0) has reported a profitable first quarter as the company advanced development of its Arizona…

Top Stock Reports for Johnson & Johnson, Oracle & Netflix

Johnson & Johnson, Oracle and Netflix lead Zacks top stock reports as analysts spotlight growth drivers, cloud gains and new…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Modular data center builder Armada raises $230 million, to build Arizona factory with new investor Johnson Controls

Modular data center builder Armada has raised $230 million from investors at a valuation of $2 billion, with BlackRock becoming…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Data presented by Johnson & Johnson at the 2026 European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting Data presented…

Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Eos Energy (EOSE) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATEWednesday, May 13, 2026 at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Joseph MastrangeloChief Operating Officer…

Legend Biotech (LEGN) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Ying HuangPresident, CARVYKTI —…

Halozyme (HALO) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DateMonday, May 11, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Helen TorleyInterim Chief Financial…

Tomi (TOMZ) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DATEFriday, May 8, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Halden ShaneChief Financial Officer…

Johnson Controls: Strong Backlog And Pricing Power Support Buy Rating

…

Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?

Its hard to argue against its reliability.…

Johnson Controls raises annual profit forecast on data center cooling demand

U.S. industrial supplier Johnson Controls International on Wednesday raised its annual profit forecast above Wall Street estimates, banking on ?rising…

Johnson Controls Tops Q2 Earnings & Revenue Estimates, Raises FY26 View

JCI beats Q2 estimates and raises FY26 outlook as strong HVAC and services demand boosts growth across all regions.…

Johnson & Johnson reaches a milestone for one of its most exciting pipeline products

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug

Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to…

Microsoft (MSFT) Q3 2026 Earnings Transcript

Image source: The Motley Fool.DateWednesday, Apr. 29, 2026 at 5:30 p.m. ETCall participantsChairman and Chief Executive Officer — Satya NadellaChief…

Equinix (EQIX) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DateApril 29, 2026 at 5:30 p.m. ETCall participantsChief Executive Officer — Adaire Fox-MartinChief Financial Officer —…

J&J sees AI halving the time to generate drug development leads

Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for…

Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports

Johnson & Johnson will start marketing four of its ?medications on the Trump administrations TrumpRx website on Friday, CBS News…

Jim Cramer Called Johnson & Johnson “The Best Drug Stock, or at Least the Second-Best”

Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s stock calls on Mad Money recently. Cramer highlighted buying the stock for…

Guggenheim raises Johnson & Johnson stock price target on Icotyde

Guggenheim raises Johnson & Johnson stock price target on Icotyde…

Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?

Solid results werent impressive enough to move the stock price higher.…

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims…

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic…

dpa-AFX ProFeed